pricing

GH Research Announces Pricing of $150 Million Public OfferingGH Research Announces Pricing of $150 Million Public Offering

GH Research Announces Pricing of $150 Million Public Offering

DUBLIN, Feb. 05, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the…

4 months ago
Maze Therapeutics Announces Pricing of Upsized Initial Public OfferingMaze Therapeutics Announces Pricing of Upsized Initial Public Offering

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

January 30, 2025 19:30 ET  | Source: Maze Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) --…

4 months ago
Wearable Devices Ltd. Announces Pricing of $2.5 Million Public OfferingWearable Devices Ltd. Announces Pricing of $2.5 Million Public Offering

Wearable Devices Ltd. Announces Pricing of $2.5 Million Public Offering

January 28, 2025 20:00 ET  | Source: Wearable Devices Ltd. Yokneam Illit, Israel, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Wearable…

4 months ago
Ascentage Pharma Announces Pricing of U.S. Initial Public OfferingAscentage Pharma Announces Pricing of U.S. Initial Public Offering

Ascentage Pharma Announces Pricing of U.S. Initial Public Offering

January 23, 2025 18:41 ET  | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL ROCKVILLE, Md. and SUZHOU, China, Jan. 23, 2025 (GLOBE…

4 months ago
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public OfferingAEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

January 06, 2025 09:00 ET  | Source: AEON Biopharma IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc.…

5 months ago
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public OfferingAEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

January 06, 2025 09:00 ET  | Source: AEON Biopharma IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc.…

5 months ago
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public OfferingPark Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on…

5 months ago
Candel Therapeutics Announces Pricing of Public OfferingCandel Therapeutics Announces Pricing of Public Offering

Candel Therapeutics Announces Pricing of Public Offering

NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused…

5 months ago
CG Oncology Announces Pricing of Public OfferingCG Oncology Announces Pricing of Public Offering

CG Oncology Announces Pricing of Public Offering

IRVINE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on…

5 months ago
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq RulesMainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

December 12, 2024 20:00 ET | Source: Mainz BioMed NV BERKELEY, Calif. and MAINZ, Germany, Dec. 12, 2024 (GLOBE NEWSWIRE)…

5 months ago
Show more Posts
Show previous Posts